CERo Therapeutics (CERO) Q2 2025 Earnings

15MayConfirmed
Q2 2025
-119.2
-104.63
-90.07
-75.5

Details

Expected EPS
-75.5
Actual EPS
-119.198
Surprise EPS
-43.7
Surprise Percent
+57.88%

Description

CERo Therapeutics (CERO) has reported earnings of -119.198 per share for Q2 2025.

0 Comments

Share your thoughts